Tom Sabia

Tom Sabia is an experienced executive in the biotechnology and pharmaceutical sectors, currently serving as Chief Commercial Officer at Quince Therapeutics. Previously, Tom held significant roles at Spark Therapeutics, Inc., including Global Commercial Development Lead for Liver Directed Gene Therapy Targets and US Commercial Development Lead for Hemophilia. At Sobi - Swedish Orphan Biovitrum AB, Tom was Vice President of Haemophilia Marketing and Operations and Senior Director for Haemophilia Global Commercial Lead. Tom's background also includes key marketing and sales positions at CSL Behring and Sanofi, where Tom managed various aspects of coagulation disorders, immunology, aesthetics, and dermatology.